SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-14-001673
Filing Date
2014-05-07
Accepted
2014-05-07 08:52:47
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT FOR 03-31-2014 txmd-10q_050114.htm 10-Q 433605
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 12321
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 12346
4 SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 6544
5 SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 6060
  Complete submission text file 0001387131-14-001673.txt   3731374

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE txmd-20140331.xml EX-101.INS 445302
7 XBRL SCHEMA FILE txmd-20140331.xsd EX-101.SCH 37247
8 XBRL CALCULATION FILE txmd-20140331_cal.xml EX-101.CAL 61998
9 XBRL DEFINITION FILE txmd-20140331_def.xml EX-101.DEF 121784
10 XBRL LABEL FILE txmd-20140331_lab.xml EX-101.LAB 287348
11 XBRL PRESENTATION FILE txmd-20140331_pre.xml EX-101.PRE 217196
Mailing Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487
Business Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 14818986
SIC: 2834 Pharmaceutical Preparations